Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02540876
Title Ilorasertib in Treating Patients With CDKN2A-deficient Advanced or Metastatic Solid Cancers That Cannot Be Removed by Surgery
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors University of Chicago
Indications

Advanced Solid Tumor

Therapies

ABT-348

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST